Drug Research

Pharmaceutical development expert, Velesco Pharma, is initiating operations at its new state-of-the-art cGMP clinical manufacturing facility in Wixom, Michigan. Set to triple the company’s cGMP clinical trial manufacturing capacity, the newly renovated building will feature expanded processing suite space to...

Eisai Co., Ltd. announced that it has obtained the manufacturing and marketing approval in Japan for its in-house discovered orexin receptor antagonist DAYVIGO (2.5mg, 5mg, and 10mg tablets, lemborexant) for treatment of insomnia. DAYVIGO is a dual orexin receptor antagonist...

Eisai Co., Ltd. announced that it has entered into a joint research and development agreement with Personal Genome Diagnostics Inc. for the cancer genetics panel test, and it has initiated the research. In this joint research and development, Eisai and...

Medigene AG , a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, announces that it has entered into a research collaboration on novel cancer antigens for highly specific immunotherapies with the Universite de Montreal (UdeM) and...

Predictive Oncology Inc , a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery, announces it has signed a letter of intent to acquire Quantitative Medicine. Dr. Carl Schwartz, president and CEO of Predictive Oncology, believes...

FDF China, collocated with CPhI China, will be held from June 22-24, 2020 at Shanghai New International Expo Centre (SNIEC). More and more formulation enterprises need to implement strategic layout to step up cooperation in innovation and facilitate the...

As the pharmaceutical market demands in China continue to grow, China’s pharmaceutical policies become gradually clear, which provides broad space for the development of pharmaceutical enterprises. The CRO & CMO industry, an important part of the R&D industry chain...